Nu-Med Plus (NUMD) Cash from Investing Activities (2012 - 2022)
Nu-Med Plus' (NUMD) quarterly Cash from Investing Activities came in at $3000.0 in Q1 2022, up 299900.0% quarter-over-quarter from $1.0 in Q4 2018.
Powered by 
Analysis
Nu-Med Plus (NUMD) Cash from Investing Activities (2012 - 2022) Analysis & Trends
Nu-Med Plus has disclosed Cash from Investing Activities across 5 years of filings, most recently posting $3000.0 for Q1 2022.
- In Q1 2022, Cash from Investing Activities changed N/A year-over-year to $3000.0; the TTM figure through Sep 2022 stood at $3000.0 (changed N/A YoY), while the FY2018 annual figure was -$5025.0, changed N/A from the prior year.
- Cash from Investing Activities came in at $3000.0 for Q1 2022 at Nu-Med Plus, up from $1.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $3000.0 in Q1 2022 to a low of -$5026.0 in Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2018 | 1.00 |
| Jun 30, 2018 | -5,026.00 |
| Dec 31, 2014 | -1,101.00 |
| Sep 30, 2013 | -1,679.00 |
| Dec 31, 2012 | -19,354.00 |
| Sep 30, 2012 | -1.00 |
| Jun 30, 2012 | -18,835.00 |